Comparison of Three Different Regimens of Oral Azithromycin in the Treatment of Acne Vulgaris

Background: Acne vulgaris is a common skin disease that involves pilosebaceous units. Orally administered antibiotics are the most widely systemic therapeutics prescribed for the treatment of moderate to severe acne vulgaris. Azithromycin is among the antibiotics that have been recently used in acne...

Full description

Bibliographic Details
Main Authors: Farahnaz Fatemi Naeini, Hooman Akrami
Format: Article
Language:fas
Published: Isfahan University of Medical Sciences 2012-03-01
Series:مجله دانشکده پزشکی اصفهان
Subjects:
Online Access:http://jims.mui.ac.ir/index.php/jims/article/view/1732
_version_ 1797712254075928576
author Farahnaz Fatemi Naeini
Hooman Akrami
author_facet Farahnaz Fatemi Naeini
Hooman Akrami
author_sort Farahnaz Fatemi Naeini
collection DOAJ
description Background: Acne vulgaris is a common skin disease that involves pilosebaceous units. Orally administered antibiotics are the most widely systemic therapeutics prescribed for the treatment of moderate to severe acne vulgaris. Azithromycin is among the antibiotics that have been recently used in acne treatment. There are several protocols for oral administration of azithromycin. Our aim was to compare three different oral regimens of azithromycin in the treatment of acne vulgaris. Methods: Sixty-four patients with moderate to severe acne were divided into three groups randomly. First group (21 patients) received azithromycin as follows: five consecutive days per month, 500 mg on the first day and 250 mg daily for the next four days. Second group (22 patients) received 500 mg daily for four consecutive days per month and the last group (21 patients) was administered 250 mg daily thrice weekly. After the baseline visit, patients were scheduled to return at four-weekly intervals for 12 weeks. Findings: Oral azithromycin in all groups resulted in a significant decrease in acne grading score in consecutive visits (P < 0.001). There was no difference between the three groups in the decreasing trend of acne grading score (P > 0.05). The efficacy of the minimum dose was equal to the maximum dose of azithromycin in our experiment. Conclusion: Because of the high cost of azithromycin, we recommend administering lower doses (1500 mg/month), which is as effective as higher doses (3000 mg/month) and has better compliance and fewer side-effects.
first_indexed 2024-03-12T07:19:01Z
format Article
id doaj.art-37f1a7b4037a4349a3d88cb83ad66658
institution Directory Open Access Journal
issn 1027-7595
1735-854X
language fas
last_indexed 2024-03-12T07:19:01Z
publishDate 2012-03-01
publisher Isfahan University of Medical Sciences
record_format Article
series مجله دانشکده پزشکی اصفهان
spelling doaj.art-37f1a7b4037a4349a3d88cb83ad666582023-09-02T22:36:14ZfasIsfahan University of Medical Sciencesمجله دانشکده پزشکی اصفهان1027-75951735-854X2012-03-0129173902Comparison of Three Different Regimens of Oral Azithromycin in the Treatment of Acne VulgarisFarahnaz Fatemi Naeini0Hooman Akrami1Associate Professor, Skin Diseases and Leishmaniasis Research Center And Department of Dermatology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, IranSkin and Stem Cell Research Center, Tehran University of Medical Sciences, Tehran And Department of Dermatology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, IranBackground: Acne vulgaris is a common skin disease that involves pilosebaceous units. Orally administered antibiotics are the most widely systemic therapeutics prescribed for the treatment of moderate to severe acne vulgaris. Azithromycin is among the antibiotics that have been recently used in acne treatment. There are several protocols for oral administration of azithromycin. Our aim was to compare three different oral regimens of azithromycin in the treatment of acne vulgaris. Methods: Sixty-four patients with moderate to severe acne were divided into three groups randomly. First group (21 patients) received azithromycin as follows: five consecutive days per month, 500 mg on the first day and 250 mg daily for the next four days. Second group (22 patients) received 500 mg daily for four consecutive days per month and the last group (21 patients) was administered 250 mg daily thrice weekly. After the baseline visit, patients were scheduled to return at four-weekly intervals for 12 weeks. Findings: Oral azithromycin in all groups resulted in a significant decrease in acne grading score in consecutive visits (P < 0.001). There was no difference between the three groups in the decreasing trend of acne grading score (P > 0.05). The efficacy of the minimum dose was equal to the maximum dose of azithromycin in our experiment. Conclusion: Because of the high cost of azithromycin, we recommend administering lower doses (1500 mg/month), which is as effective as higher doses (3000 mg/month) and has better compliance and fewer side-effects.http://jims.mui.ac.ir/index.php/jims/article/view/1732Acne vulgarisAzithromycinTherapeutic equivalency
spellingShingle Farahnaz Fatemi Naeini
Hooman Akrami
Comparison of Three Different Regimens of Oral Azithromycin in the Treatment of Acne Vulgaris
مجله دانشکده پزشکی اصفهان
Acne vulgaris
Azithromycin
Therapeutic equivalency
title Comparison of Three Different Regimens of Oral Azithromycin in the Treatment of Acne Vulgaris
title_full Comparison of Three Different Regimens of Oral Azithromycin in the Treatment of Acne Vulgaris
title_fullStr Comparison of Three Different Regimens of Oral Azithromycin in the Treatment of Acne Vulgaris
title_full_unstemmed Comparison of Three Different Regimens of Oral Azithromycin in the Treatment of Acne Vulgaris
title_short Comparison of Three Different Regimens of Oral Azithromycin in the Treatment of Acne Vulgaris
title_sort comparison of three different regimens of oral azithromycin in the treatment of acne vulgaris
topic Acne vulgaris
Azithromycin
Therapeutic equivalency
url http://jims.mui.ac.ir/index.php/jims/article/view/1732
work_keys_str_mv AT farahnazfateminaeini comparisonofthreedifferentregimensoforalazithromycininthetreatmentofacnevulgaris
AT hoomanakrami comparisonofthreedifferentregimensoforalazithromycininthetreatmentofacnevulgaris